WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the JMP Securities Sector Focus Conference on November 16, 2006 in Boston, MA. President and CEO, Steven Rauscher, will provide an overview of the Company including details on the acquisition of ANTARA(R) 130 mg (fenofibrate) capsules and preparations for the third winter season for FACTIVE(R) (gemifloxacin mesylate) tablets.
